{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:40:09Z","timestamp":1787319609196,"version":"build-2736575974"},"reference-count":44,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The aim of the study was to evaluate the serological rate of Helicobacter pylori (H. pylori) infection in patients with chronic hepatitis C virus (HCV) infection and determine any correlations with liver damage and IL28B single-nucleotide polymorphism (SNP). One hundred eighty-nine patients with chronic HCV infection were included in the study, and H. pylori status was defined based on anti-H. pylori-IgG or anti-CagA-IgG antibodies using enzyme-linked immunosorbent assay (ELISA). Liver damage was assessed using histology or transient elastography. IL28B C\/T polymorphism (rs12979860) was evaluated in circulating blood cells using a PCR-based restriction fragment length polymorphism assay. Overall H. pylori serology was positive in 38.1% of our HCV-infected subjects. Among those, the anti-CagA-IgG positivity rate was 43.1% and was within the range of previously described populations of the same region. Highest prevalence of H. pylori was found in patients between 31 and 40 years compared to other age subgroups. The seropositivity rate was higher in the non-cirrhotic group than the cirrhotic one (45.4% vs. 20.0%, p &lt; 0.05). No difference was found in IL28B genotype between H. pylori-positive and -negative cohorts. However, we observed a trend for the lower anti-CagA-IgG expression level in relation to the IL28B T-allele. Our results do not support an association between HCV and H. pylori infection. Whether IL28B SNP has a functional role in modulation of serological response to H. pylori CagA needs further investigation.<\/jats:p>","DOI":"10.3390\/jcm7030044","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T07:37:25Z","timestamp":1520321845000},"page":"44","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism"],"prefix":"10.3390","volume":"7","author":[{"given":"Alexander","family":"Gutwerk","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wex","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"},{"name":"Medical Laboratories for Clinical Chemistry, Microbiology and Infectious Diseases, Department of Molecular Genetics, 39124 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosima","family":"Langner","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-4562","authenticated-orcid":false,"given":"Alexander","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","article-title":"Hepatitis C","volume":"385","author":"Webster","year":"2015","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00103-013-1673-x","article-title":"Die Seroepidemiologie der Hepatitis A, B und C in Deutschland","volume":"56","author":"Zimmermann","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Vermehren, J., Schlosser, B., Domke, D., Elanjimattom, S., M\u00fcller, C., Hintereder, G., Hensel-Wiegel, K., Tauber, R., and Berger, A. (2012). High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: A prospective screening analysis of 28,809 patients. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041206"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1331\/JAPhA.2015.15508","article-title":"Hepatitis C therapy: Looking toward interferon-sparing regimens","volume":"55","author":"Au","year":"2015","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0028-1110008","article-title":"Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion, AWMF-Register-Nr.: 021\/012. Prophylaxis, diagnosis and therapy of Hepatitis C virus (HCV) infection: The German guidelines on the management of HCV infection","volume":"48","author":"Sarrazin","year":"2010","journal-title":"Z. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","article-title":"Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010","volume":"63","author":"Allison","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A hospital-based case? control study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrgastro.2014.99","article-title":"Helicobacter pylori: Perspectives and time trends","volume":"11","author":"Malfertheiner","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/CMR.10.4.720","article-title":"Helicobacter pylori","volume":"10","author":"Dunn","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/CVI.05308-11","article-title":"Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010","volume":"18","author":"Wex","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2036.11.s1.5.x","article-title":"Helicobacter pylori and the risk and management of associated diseases: Gastritis, ulcer disease, atrophic gastritis and gastric cancer","volume":"11","author":"Kuipers","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.bjc.6604780","article-title":"Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract","volume":"100","author":"Plummer","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3748\/wjg.14.307","article-title":"Association between the presence of H pylori in the liver and hepatocellular carcinoma: A meta-analysis","volume":"14","author":"Xuan","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_16","first-page":"959","article-title":"Chronic active hepatitis in mice caused by Helicobacter hepaticus","volume":"145","author":"Ward","year":"1994","journal-title":"Am. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8780695","DOI":"10.1155\/2016\/8780695","article-title":"The Association between Helicobacter pylori infection and chronic hepatitis C: A meta-analysis and trial sequential analysis","volume":"2016","author":"Wang","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of Genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5152\/balkanmedj.2015.15156","article-title":"Characterization of the interleukin-28B gene rs12979860 C\/T polymorphism in Turkish chronic hepatitis C patients and healthy individuals","volume":"32","author":"Taheri","year":"2015","journal-title":"Balkan Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10875-011-9547-1","article-title":"Role of interleukin 28B rs12979860 C\/T polymorphism on the histological outcome of chronic hepatitis C: Relationship with gender and viral genotype","volume":"31","author":"Falleti","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2014.11.002","article-title":"Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study","volume":"113","author":"Bruno","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_23","first-page":"216","article-title":"Polymophism of IL-28B gene (rs12979860) in HCV genotype 1 patients treated by pegylated interferon and ribavirin","volume":"11","author":"Tameshkel","year":"2016","journal-title":"Iran. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2014.09.021","article-title":"Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus Genotype 3 patients to pegylated interferon therapy","volume":"30","author":"Aziz","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.07.041","article-title":"Importance of IL28B gene polymorphisms in hepatitis C virus Genotype 2 and 3 infected patients","volume":"54","author":"Sarrazin","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/1751-2980.12497","article-title":"Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome","volume":"18","author":"Khubaib","year":"2017","journal-title":"J. Dig. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2011.05.024","article-title":"Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study","volume":"56","author":"Zarski","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.3748\/wjg.v23.i26.4712","article-title":"Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA","volume":"23","author":"Link","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0043-106311","article-title":"Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany\u2014A region at intermediate risk for gastric cancer","volume":"55","author":"Franck","year":"2017","journal-title":"Z. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5651903","DOI":"10.1155\/2017\/5651903","article-title":"Perioperative therapy of oesophagogastric adenocarcinoma: Mainstay and future directions","volume":"2017","author":"Bose","year":"2017","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hel.12332","article-title":"Epidemiology of Helicobacter pylori infection","volume":"21","author":"Leja","year":"2016","journal-title":"Helicobacter"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1055-9965.EPI-12-1343","article-title":"Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: Evidence from a large population-based study in Germany","volume":"22","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21101\/cejph.a3890","article-title":"Helicobacter pylori prevalence in children influenced by non-specific antibiotic treatments","volume":"22","author":"Hoffmann","year":"2014","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1002\/hep.1840360714","article-title":"Maternal-Infant Transmission","volume":"36","author":"Roberts","year":"2002","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<111::AID-JMV4>3.0.CO;2-C","article-title":"Heterosexual transmission of hepatitis C in Italy","volume":"57","author":"Mele","year":"1999","journal-title":"J. Med. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/apt.13474","article-title":"Review article: The prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe","volume":"43","author":"Roberts","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12250","article-title":"Epidemiology and diagnosis of Helicobacter pylori infection","volume":"20","author":"Mentis","year":"2015","journal-title":"Helicobacter"},{"key":"ref_39","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2014). European Drug Report 2014: Trends and Developments, European Monitoring Centre for Drugs and Drug Addiction."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fimmu.2013.00328","article-title":"Helicobacter pylori CagA: From pathogenic mechanisms to its use as an anti-cancer vaccine","volume":"4","author":"Stein","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijmm.2004.06.014","article-title":"Helicobacter pylori: Recombination, population structure and human migrations","volume":"294","author":"Suerbaum","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jurban\/jti093","article-title":"Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia","volume":"82","author":"Olivares","year":"2005","journal-title":"J. Urban Health"},{"key":"ref_43","first-page":"310","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"66","author":"Abraldes","year":"2017","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.10466","article-title":"Genetic susceptibility and gastric cancer risk","volume":"100","author":"Sala","year":"2002","journal-title":"Int. J. Cancer"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/3\/44\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:57:33Z","timestamp":1760194653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/3\/44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["jcm7030044"],"URL":"https:\/\/doi.org\/10.3390\/jcm7030044","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]}}}